Avid Bioservices Inc (CDMO)

[biopharm]

since Peregrine now releases they have "24" at the miniumum in progress and pre-clinical Bruce Friemark has been on the PAV list of Troy Luster for many months now, along with Dr. Brekken and other UTSWM profiles... and still would be interesting to find out why Troy leaves such historic potential/breakthroughs soon to hopefully be announced : )

-------------------------------------------------------

page 16/17 ... drug molecules : "not disclosed"

http://evotec.sissy.bgcc.at/uploads/media_library/10/2014-09_Evotec_Company_presentation_September_e.pdf

--------------------------------------------------------

Edison Investment Research ... owns EvoTech, where Troy Luster working with now out of Dana Farber and they have listed here a few drugs not being disclosed:

pg.4
Target Sx ... Target Kx.. and one undisclosed: -- no info on all three

pg 5.
Not disclosed Phase I Oncology/
Boehringer Ingelheim
Boehringer Ingelheim initiated a Phase I trial with an oncology compound in September 2013, triggering a €2m payment to Evotec. No further details have been disclosed

Sept 12, 2014

here is the cached link:
http://webcache.googleusercontent.com/search?q=cache:hZD19CDpdR4J:www.edisoninvestmentresearch.com/%3FACT%3D18%26ID%3D12697+&cd=1&hl=en&ct=clnk&gl=us

or its the 1st link, pdf file... just out today Sept 12, 2014

https://www.google.com/?gws_rd=ssl#q=evotec+belfer+institute&tbs=qdr:m

Looks like Evotech was part of a plan all along, especially with Dana Farber ties and anyone ever hear of Proteros Biostructures? Why would Merck have had an interest in Proteros and PS Targeting

Longtime Peregrine shareholder and continued Avid Bioservices shareholder parent company Dart Neuroscience officially out of business soon